/PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has become the first.
FRANKLIN LAKES, N.J., May 26, 2021 /PRNewswire/ BD , a leading global medical technology company, today announced that it will present at the following upcoming virtual investor conferences. | May 26, 2021
BD to Present at Upcoming Investor Conferences in June
News provided by
Share this article
Share this article
FRANKLIN LAKES, N.J., May 26, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following upcoming virtual investor conferences during the month of June:
The Piper Sandler June Med Tech Series Conference on Friday, June 4, 2021 at 1:30 p.m. Eastern Time (ET).
The Goldman Sachs 42
nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, at 8:50 a.m. Eastern Time (ET).
Live webcasts of BD s presentations, along with any related materials, can be accessed on the BD corporate website at www.bd.com/investors. A replay will be available for a minimum of seven days after each conference.
Share this article
Share this article
FRANKLIN LAKES, N.J., May 25, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the availability of BD Surgiphor™ Sterile Wound Irrigation System, the first and only ready-to-use aqueous povidone-iodine (PVP-I) irrigation solution that mechanically loosens and removes wound debris.
BD Surgiphor sterile wound irrigation system
BD Surgiphor™ is a pre-mixed, pre-labeled, single patient surgical wound irrigation solution. BD Surgiphor™ uses PVP-I, a well-known antiseptic agent, as a preservative within the solution providing a broad-spectrum antimicrobial effect against gram-positive and gram-negative bacteria and yeast to reduce the risk of unwanted microbial growth in the solution after the bottle is opened.
BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain To Support Ongoing Strong Growth of Pre-Filled Drug Delivery BusinessNew plant will produce drug delivery devices, employ 150 people in 2024 and up to 600 when full operations start in 2030MADRID, Spain, May 18, 2021 / B3C newswire / BD (.